Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00311441
Status:
COMPLETED
Last Update Posted:
2008-03-17
First Post:
2006-04-03
Brief Title:
Study of the Safety Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Phase IV Randomized Controlled Single-Blind Multi-Center Study in Children to Evaluate the Safety Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety immunogenicity and tolerability of TBE vaccines administered to children
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 911 | None | None | None |